Cipla
Girish Gaur serves as the Head of Americas - API Sales & Marketing at Cipla since January 2024, following a tenure in similar leadership positions at Jubilant Pharmova Limited and Cadila Pharmaceuticals Limited. Gaur possesses extensive experience in international B2B sales management, revenue growth, business development, and key account management, having held senior marketing roles at various organizations, including Jubilant Life Sciences Ltd. and Kumar Organic Products Limited. Gaur's educational background includes a Master's degree in Organic Chemistry from the University of Mumbai and an MBA specializing in Marketing from the Mumbai Educational Trust.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.